Pablo A. Guzman's most recent trade in ZyVersa Therapeutics Inc was a trade of 100,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 26, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ZyVersa Therapeutics Inc | Pablo A. Guzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 100,000 | 100,000 | - | - | Stock Options (right to buy) |